Skip to contentC
cbdMD, Inc.
C
YCBDcbdMD, Inc. Q1 2024 · 10-Q
Revenue$5.38M$5.38M−11.7% vs Q1 2023 Net Income-$996.50K-$996.50KN/M vs Q1 2023 EPS, diluted—
Gross Profit$3,557,498−0.3% Operating Income-$1,065,835N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
cbdMD, Inc. · CIK 1644903 · Engraved from SEC EDGAR
Operating Cash Flow-$105,880N/M Free Cash Flowderived-$290,515N/M Margins · derivedGross margin66.2%+7.6 pt vs Q1 2023
Operating margin-19.8%+46.7 pt vs Q1 2023
Net margin-18.5%+46.5 pt vs Q1 2023
ended Dec 31, 2023 · filed Feb 13, 2024 · 44 d after period end